Connect with us

Hi, what are you looking for?

DOGE0.070.84%SOL19.370.72%USDC1.000.01%BNB287.900.44%AVAX15.990.06%XLM0.080.37%
USDT1.000%XRP0.392.6%BCH121.000.75%DOT5.710.16%ADA0.320.37%LTC85.290.38%
THE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & LifestyleTHE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & Lifestyle

Business

Business

Bristol-Myer’s New Melanoma Drug Receives Accelerated Approval

Bristol Myers Squibb Bristol Myers Squibb
Bristol Myers Squibb Bristol Myers Squibb

Bristol-Myers Squibb is one the leading pharmaceutical companies around the world, and they were just granted approval from the Food and Drug Administration to start releasing a new drug that will help patients with Melanoma.

Opdivo is the new drug being released by BMS, after being confirmed as a beneficial drug that will severely help patients who are diagnosed with Melanoma.

There is an estimated 76,100 people in the United States alone that suffer from this deadly skin disease, and a good majority of those infected with the disease may die at the hands of it. According to the FDA’s official website, Melanoma is the fifth most common type of cancer in the United States, and forms within the melanocyte cells, the cells that are responsible for developing skin pigmentation. Researchers have been trying to find new ways to cure this common disease, and there have been seven drugs approved the FDA for Melanoma since 2011.

The drug reportedly works by shrinking tumors on the skin for patients, and it goes after cancer cells. The drug was not going to be released just yet, but received accelerated approval after one third of the patients who were in trial with it showed signs of tumor shrinkage.

While Melanoma is a deadly disease, the approval of Opdivo has given a lot of people a chance at fighting this condition.

 

 


Comment Template

You May Also Like

Business

In the wake of Walmart’s departure as a major stakeholder and a stagnating Chinese e-commerce market, JD.com must persuade investors of its importance. This...

Economy

Friday saw dollar weakness as investors braced for Jackson Hole address by Federal Reserve Chair Jerome Powell, while the yen topped other currencies in...

Politics

  Joe Biden had other plans for his address. Under the current conditions, at least not this year. Tragedies and hardships have left their...

Economy

After a bank official was freed from captivity, activities at Libya’s central bank (CBL) were restored. Musaab Muslamm, chief of the bank’s information technology...

Notice: The Biznob uses cookies to provide necessary website functionality, improve your experience and analyze our traffic. By using our website, you agree to our Privacy Policy and our Cookie Policy.

Ok